NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy
In Brief: Gregory Curt Nominated DCT Deputy DCC Seeks Occupational Cancer, Prevention Branch Chiefs
DC, DCR Boards Angered when NCI Ignored In AIDS Money Amendment
DCT Board Okays 11 Concept Contract Recompetitions
NCI Advisory Group, Other Cancer Meetings
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- A new diagnostic lens—and a lasting scientific legacy
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









